SF3B1 promotes tumor malignancy through splicing-independent co-activation of HIF1α
| Autor: | Simmler, Patrik T, Cortijo, Cédric, Koch, Lisa M, Galliker, Patricia, Angori, Silvia, Bolck, Hella A, Mueller, Christina, Vukolic, Ana, Mirtschink, Peter, Christinat, Yann, Davidson, Natalie R, Lehmann, Kjong-Van, Pellegrini, Giovanni, Pauli, Chantal, Lenggenhager, Daniela, Guccini, Ilaria, Ringel, Till, Hirt, Christian, Rätsch, Gunnar, Moch, Holger, Stoffel, Markus, Schwank, Gerald |
|---|---|
| Přispěvatelé: | University of Zurich |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | bioRxiv |
| Popis: | Heterozygous mutations in the splicing factor SF3B1 are frequently occurring in various cancers and drive tumor progression through the activation of cryptic splice sites in multiple genes. Recent studies moreover demonstrate a positive correlation between expression levels of wildtype SF3B1 and tumor malignancy, although the underlying mechanisms for this phenomenon remain elusive. Here, we report that SF3B1 acts as a coactivator for hypoxia-inducible factor (HIF)1α through a splicing-independent mechanism. By directly interacting with HIF1α, SF3B1 augments HIF1α-HIF1β heterodimer binding to hypoxia response elements, and facilitates full transcriptional response of HIF target genes. We further validate the relevance of this mechanism for tumor progression, and show that monoallelic deletion of Sf3b1 impedes pancreatic cancer formation via HIF signaling. Altogether our work demonstrates a pivotal role of SF3B1 in the adaptation to hypoxia, suggesting a causal link between high SF3B1 levels and cancer aggressiveness.Competing Interest StatementThe authors have declared no competing interest. bioRxiv |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|